A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1

A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1

Bibliographic Details
Main Authors:	Haisheng Yu, Pengle Guo, Yingyin Yang, Jun Dai, Xiaoping Tang, Linghua Li, Yanjie Yin
Format:	Article
Language:	English
Published:	Wolters Kluwer 2023-09-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000002810

Similar Items

Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV
by: Lorie Marchitto, et al.
Published: (2023-09-01)

A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV
by: Zhengchao Lv, et al.
Published: (2023-11-01)

Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV
by: Shi Zou, et al.
Published: (2022-10-01)

Humoral immune response to inactivated COVID-19 vaccination at the 3rd month among people living with HIV
by: Songjie Wu, et al.
Published: (2023-01-01)

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
by: Alrubayyi, A, et al.
Published: (2021)

Advances in diagnosis and treatment of talaromycosis in patients with AIDS
by: Pengle Guo, et al.
Published: (2022-11-01)

Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice.
by: Shana P C Barroso, et al.
Published: (2015-01-01)

Weak SARS-CoV-2-specific responses of TIGIT-expressing CD8+ T cells in people living with HIV after a third dose of a SARS-CoV-2 inactivated vaccine
by: Junyan Jin, et al.
Published: (2023-12-01)

A tale of two conditions: when people living with HIV meet three doses of inactivated COVID-19 vaccines
by: Yuting Tan, et al.
Published: (2023-06-01)

Humoral Responses Elicited after a Fifth Dose of SARS-CoV-2 mRNA Bivalent Vaccine
by: Alexandra Tauzin, et al.
Published: (2023-09-01)

Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV
by: Majdouline El Moussaoui, et al.
Published: (2023-06-01)

A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain
by: Ji Wang, et al.
Published: (2022-11-01)

Lower SARS-CoV-2–specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19
by: Daniel J. Schuster, et al.
Published: (2022-11-01)

Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China
by: Yunyun Yi, et al.
Published: (2023-05-01)

Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review
by: Valentina Carta, et al.
Published: (2024-12-01)

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
by: Zabrina L. Brumme, et al.
Published: (2022-02-01)

Effect of SARS-CoV-2 Breakthrough Infection on HIV Reservoirs and T-Cell Immune Recovery in 3-Dose Vaccinated People Living with HIV
by: Meng-Meng Qu, et al.
Published: (2023-12-01)

Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China
by: Xiaojie Huang, et al.
Published: (2022-01-01)

Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
by: Vivek P. Chavda, et al.
Published: (2022-02-01)

Characterization of early immune responses elicited by live and inactivated vaccines against Johne's disease in goats
by: Mostafa Hanafy, et al.
Published: (2023-01-01)

Previous Infection with SARS-CoV-2 Correlates with Increased Protective Humoral Responses after a Single Dose of an Inactivated COVID-19 Vaccine
by: Flávia F. Bagno, et al.
Published: (2022-03-01)

Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals
by: Shi Zou, et al.
Published: (2022-07-01)

Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors
by: Zhiwei Chen, et al.
Published: (2023-02-01)

Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants
by: Chun-Hsiang Chiu, et al.
Published: (2022-10-01)

Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants
by: Yubin Liu, et al.
Published: (2023-04-01)

Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
by: Alessandra Vergori, et al.
Published: (2022-08-01)

Cellular and Humoral Responses to Recombinant and Inactivated SARS-CoV-2 Vaccines in CKD Patients: An Observational Study
by: Siliang Zhang, et al.
Published: (2023-02-01)

Waning humoral immune responses to inactivated SARS-CoV-2 vaccines in patients with severe liver disease
by: Zhiwei Chen, et al.
Published: (2022-06-01)

Humoral Bone Morphogenetic Protein 2 Is Sufficient for Inducing Breast Cancer Microcalcification
by: Fangbing Liu, et al.
Published: (2008-07-01)

Plant-Expressed Receptor Binding Domain of the SARS-CoV-2 Spike Protein Elicits Humoral Immunity in Mice
by: Puna Maya Maharjan, et al.
Published: (2021-09-01)

SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice
by: Eun Kim, et al.
Published: (2023-06-01)

Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human
by: Yuwei Zhang, et al.
Published: (2022-10-01)

Lymphomas in People Living with HIV
by: Emanuela Vaccher, et al.
Published: (2022-09-01)

Meningeal cryptococcosis and SARS-CoV-2 infection in people living with HIV/AIDS
by: Fernando Antonio Messina, et al.
Published: (2023-08-01)

Durable natural killer cell response after three doses of SARS-CoV-2 inactivated vaccine in HIV-infected individuals
by: Xiaodong Yang, et al.
Published: (2023-12-01)

Inflammatory signals are sufficient to elicit TOX expression in mouse and human CD8+ T cells
by: Nicholas J. Maurice, et al.
Published: (2021-07-01)

Are single odorous components of a predator sufficient to elicit defensive behaviors in prey species?
by: Raimund eApfelbach, et al.
Published: (2015-07-01)

Evolution of anti-SARS-CoV-2 spike protein titers after two-dose of COVID-19 vaccination among people living with HIV
by: Wang-Da Liu, et al.
Published: (2022-12-01)

Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity
by: Marija Vukčević, et al.
Published: (2024-01-01)

Durability of ChAdOx1 nCov-19 vaccination in people living with HIV
by: Ogbe, A, et al.
Published: (2022)